nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—CYP2A6—esophageal cancer	0.343	0.43	CbGaD
Clomifene—CYP19A1—esophageal cancer	0.326	0.41	CbGaD
Clomifene—ABCB1—esophageal cancer	0.128	0.16	CbGaD
Clomifene—Heart malformation—Cisplatin—esophageal cancer	0.00678	0.103	CcSEcCtD
Clomifene—Heart disease congenital—Cisplatin—esophageal cancer	0.00554	0.0841	CcSEcCtD
Clomifene—Mental retardation—Capecitabine—esophageal cancer	0.00216	0.0327	CcSEcCtD
Clomifene—Phlebitis—Carboplatin—esophageal cancer	0.00184	0.0279	CcSEcCtD
Clomifene—Thromboembolic event—Capecitabine—esophageal cancer	0.00175	0.0265	CcSEcCtD
Clomifene—Vasospasm—Capecitabine—esophageal cancer	0.00138	0.0209	CcSEcCtD
Clomifene—Leukaemia—Methotrexate—esophageal cancer	0.0013	0.0198	CcSEcCtD
Clomifene—Thromboembolic event—Methotrexate—esophageal cancer	0.0013	0.0198	CcSEcCtD
Clomifene—Congenital anomaly—Capecitabine—esophageal cancer	0.00124	0.0188	CcSEcCtD
Clomifene—Developmental delay—Capecitabine—esophageal cancer	0.00124	0.0188	CcSEcCtD
Clomifene—Blindness—Cisplatin—esophageal cancer	0.00115	0.0175	CcSEcCtD
Clomifene—Optic neuritis—Cisplatin—esophageal cancer	0.00104	0.0158	CcSEcCtD
Clomifene—Ascites—Capecitabine—esophageal cancer	0.00104	0.0157	CcSEcCtD
Clomifene—Disorder sight—Capecitabine—esophageal cancer	0.000989	0.015	CcSEcCtD
Clomifene—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.00082	0.0124	CcSEcCtD
Clomifene—Visual acuity reduced—Capecitabine—esophageal cancer	0.000792	0.012	CcSEcCtD
Clomifene—Embolism—Capecitabine—esophageal cancer	0.000734	0.0111	CcSEcCtD
Clomifene—Tenderness—Cisplatin—esophageal cancer	0.000732	0.0111	CcSEcCtD
Clomifene—Blood triglycerides increased—Capecitabine—esophageal cancer	0.000719	0.0109	CcSEcCtD
Clomifene—Thrombosis—Capecitabine—esophageal cancer	0.000666	0.0101	CcSEcCtD
Clomifene—Pain—Carboplatin—esophageal cancer	0.000665	0.0101	CcSEcCtD
Clomifene—Hepatocellular injury—Cisplatin—esophageal cancer	0.000639	0.0097	CcSEcCtD
Clomifene—Body temperature increased—Carboplatin—esophageal cancer	0.000615	0.00932	CcSEcCtD
Clomifene—Embolism—Methotrexate—esophageal cancer	0.000546	0.00829	CcSEcCtD
Clomifene—Phlebitis—Cisplatin—esophageal cancer	0.000538	0.00817	CcSEcCtD
Clomifene—Cyst—Methotrexate—esophageal cancer	0.000525	0.00796	CcSEcCtD
Clomifene—Deafness—Cisplatin—esophageal cancer	0.000519	0.00787	CcSEcCtD
Clomifene—Liver disorder—Methotrexate—esophageal cancer	0.000514	0.00781	CcSEcCtD
Clomifene—Cataract—Capecitabine—esophageal cancer	0.000495	0.00751	CcSEcCtD
Clomifene—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000473	0.00718	CcSEcCtD
Clomifene—Pulmonary embolism—Capecitabine—esophageal cancer	0.000471	0.00715	CcSEcCtD
Clomifene—Tamoxifen—CYP1B1—esophageal cancer	0.000464	0.204	CrCbGaD
Clomifene—Irritability—Cisplatin—esophageal cancer	0.000443	0.00672	CcSEcCtD
Clomifene—Neoplasm—Capecitabine—esophageal cancer	0.000426	0.00646	CcSEcCtD
Clomifene—Mental disability—Capecitabine—esophageal cancer	0.000409	0.0062	CcSEcCtD
Clomifene—Phlebitis—Capecitabine—esophageal cancer	0.000397	0.00602	CcSEcCtD
Clomifene—Thrombophlebitis—Capecitabine—esophageal cancer	0.000395	0.00599	CcSEcCtD
Clomifene—Pancreatitis—Cisplatin—esophageal cancer	0.000393	0.00596	CcSEcCtD
Clomifene—Abdominal discomfort—Cisplatin—esophageal cancer	0.000384	0.00583	CcSEcCtD
Clomifene—Deafness—Capecitabine—esophageal cancer	0.000382	0.0058	CcSEcCtD
Clomifene—Eye pain—Capecitabine—esophageal cancer	0.000379	0.00575	CcSEcCtD
Clomifene—Hot flush—Capecitabine—esophageal cancer	0.000366	0.00555	CcSEcCtD
Clomifene—Increased appetite—Capecitabine—esophageal cancer	0.000364	0.00552	CcSEcCtD
Clomifene—Menopausal symptoms—Capecitabine—esophageal cancer	0.000362	0.0055	CcSEcCtD
Clomifene—Tamoxifen—ABCC2—esophageal cancer	0.000362	0.159	CrCbGaD
Clomifene—Tamoxifen—CYP2A6—esophageal cancer	0.000358	0.157	CrCbGaD
Clomifene—Renal failure—Cisplatin—esophageal cancer	0.000351	0.00533	CcSEcCtD
Clomifene—Pulmonary embolism—Methotrexate—esophageal cancer	0.000351	0.00532	CcSEcCtD
Clomifene—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000349	0.00529	CcSEcCtD
Clomifene—Diplopia—Capecitabine—esophageal cancer	0.000342	0.00519	CcSEcCtD
Clomifene—Tamoxifen—CYP19A1—esophageal cancer	0.000341	0.15	CrCbGaD
Clomifene—Migraine—Capecitabine—esophageal cancer	0.000337	0.00511	CcSEcCtD
Clomifene—Toremifene—ABCB1—esophageal cancer	0.000333	0.147	CrCbGaD
Clomifene—Irritability—Capecitabine—esophageal cancer	0.000326	0.00495	CcSEcCtD
Clomifene—Mood swings—Capecitabine—esophageal cancer	0.000324	0.00491	CcSEcCtD
Clomifene—Neoplasm—Methotrexate—esophageal cancer	0.000317	0.00481	CcSEcCtD
Clomifene—Visual impairment—Cisplatin—esophageal cancer	0.000309	0.00469	CcSEcCtD
Clomifene—Tinnitus—Cisplatin—esophageal cancer	0.000299	0.00454	CcSEcCtD
Clomifene—Flushing—Cisplatin—esophageal cancer	0.000298	0.00452	CcSEcCtD
Clomifene—Abdominal distension—Capecitabine—esophageal cancer	0.000298	0.00451	CcSEcCtD
Clomifene—Thrombophlebitis—Methotrexate—esophageal cancer	0.000294	0.00446	CcSEcCtD
Clomifene—Arrhythmia—Cisplatin—esophageal cancer	0.000287	0.00435	CcSEcCtD
Clomifene—Alopecia—Cisplatin—esophageal cancer	0.000284	0.0043	CcSEcCtD
Clomifene—Abdominal discomfort—Capecitabine—esophageal cancer	0.000283	0.0043	CcSEcCtD
Clomifene—Diphenhydramine—PTGS1—esophageal cancer	0.000281	0.124	CrCbGaD
Clomifene—Erythema—Cisplatin—esophageal cancer	0.000279	0.00424	CcSEcCtD
Clomifene—Flatulence—Cisplatin—esophageal cancer	0.000275	0.00418	CcSEcCtD
Clomifene—Weight increased—Capecitabine—esophageal cancer	0.000269	0.00408	CcSEcCtD
Clomifene—Visual disturbance—Methotrexate—esophageal cancer	0.000269	0.00408	CcSEcCtD
Clomifene—Vision blurred—Cisplatin—esophageal cancer	0.000263	0.00399	CcSEcCtD
Clomifene—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00026	0.00394	CcSEcCtD
Clomifene—Renal failure—Capecitabine—esophageal cancer	0.000259	0.00393	CcSEcCtD
Clomifene—Jaundice—Capecitabine—esophageal cancer	0.000257	0.0039	CcSEcCtD
Clomifene—Irritability—Methotrexate—esophageal cancer	0.000243	0.00369	CcSEcCtD
Clomifene—Convulsion—Cisplatin—esophageal cancer	0.000242	0.00367	CcSEcCtD
Clomifene—Mood swings—Methotrexate—esophageal cancer	0.000241	0.00366	CcSEcCtD
Clomifene—Myalgia—Cisplatin—esophageal cancer	0.000238	0.00361	CcSEcCtD
Clomifene—Anxiety—Cisplatin—esophageal cancer	0.000237	0.0036	CcSEcCtD
Clomifene—Hepatitis—Capecitabine—esophageal cancer	0.000237	0.00359	CcSEcCtD
Clomifene—Oedema—Cisplatin—esophageal cancer	0.000228	0.00346	CcSEcCtD
Clomifene—Visual impairment—Capecitabine—esophageal cancer	0.000228	0.00346	CcSEcCtD
Clomifene—Erythema multiforme—Capecitabine—esophageal cancer	0.000224	0.00339	CcSEcCtD
Clomifene—Tachycardia—Cisplatin—esophageal cancer	0.000223	0.00338	CcSEcCtD
Clomifene—Tinnitus—Capecitabine—esophageal cancer	0.000221	0.00335	CcSEcCtD
Clomifene—Flushing—Capecitabine—esophageal cancer	0.00022	0.00333	CcSEcCtD
Clomifene—Pancreatitis—Methotrexate—esophageal cancer	0.000216	0.00327	CcSEcCtD
Clomifene—Arrhythmia—Capecitabine—esophageal cancer	0.000211	0.00321	CcSEcCtD
Clomifene—Abdominal discomfort—Methotrexate—esophageal cancer	0.000211	0.0032	CcSEcCtD
Clomifene—Alopecia—Capecitabine—esophageal cancer	0.000209	0.00317	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000208	0.00315	CcSEcCtD
Clomifene—Erythema—Capecitabine—esophageal cancer	0.000206	0.00312	CcSEcCtD
Clomifene—Paraesthesia—Cisplatin—esophageal cancer	0.000205	0.00311	CcSEcCtD
Clomifene—Dyspnoea—Cisplatin—esophageal cancer	0.000203	0.00308	CcSEcCtD
Clomifene—Flatulence—Capecitabine—esophageal cancer	0.000203	0.00308	CcSEcCtD
Clomifene—Back pain—Capecitabine—esophageal cancer	0.000199	0.00302	CcSEcCtD
Clomifene—Pain—Cisplatin—esophageal cancer	0.000195	0.00296	CcSEcCtD
Clomifene—Vision blurred—Capecitabine—esophageal cancer	0.000194	0.00294	CcSEcCtD
Clomifene—Renal failure—Methotrexate—esophageal cancer	0.000193	0.00293	CcSEcCtD
Clomifene—Vertigo—Capecitabine—esophageal cancer	0.000185	0.00281	CcSEcCtD
Clomifene—Syncope—Capecitabine—esophageal cancer	0.000185	0.0028	CcSEcCtD
Clomifene—Palpitations—Capecitabine—esophageal cancer	0.000182	0.00276	CcSEcCtD
Clomifene—Loss of consciousness—Capecitabine—esophageal cancer	0.000181	0.00275	CcSEcCtD
Clomifene—Body temperature increased—Cisplatin—esophageal cancer	0.00018	0.00273	CcSEcCtD
Clomifene—Hypertension—Capecitabine—esophageal cancer	0.000178	0.0027	CcSEcCtD
Clomifene—Hepatitis—Methotrexate—esophageal cancer	0.000176	0.00267	CcSEcCtD
Clomifene—Arthralgia—Capecitabine—esophageal cancer	0.000175	0.00266	CcSEcCtD
Clomifene—Chest pain—Capecitabine—esophageal cancer	0.000175	0.00266	CcSEcCtD
Clomifene—Myalgia—Capecitabine—esophageal cancer	0.000175	0.00266	CcSEcCtD
Clomifene—Anxiety—Capecitabine—esophageal cancer	0.000175	0.00265	CcSEcCtD
Clomifene—Visual impairment—Methotrexate—esophageal cancer	0.00017	0.00257	CcSEcCtD
Clomifene—Oedema—Capecitabine—esophageal cancer	0.000168	0.00255	CcSEcCtD
Clomifene—Hypersensitivity—Cisplatin—esophageal cancer	0.000168	0.00255	CcSEcCtD
Clomifene—Erythema multiforme—Methotrexate—esophageal cancer	0.000167	0.00253	CcSEcCtD
Clomifene—Shock—Capecitabine—esophageal cancer	0.000165	0.00251	CcSEcCtD
Clomifene—Tinnitus—Methotrexate—esophageal cancer	0.000164	0.00249	CcSEcCtD
Clomifene—Tachycardia—Capecitabine—esophageal cancer	0.000164	0.00249	CcSEcCtD
Clomifene—Asthenia—Cisplatin—esophageal cancer	0.000164	0.00248	CcSEcCtD
Clomifene—Diarrhoea—Cisplatin—esophageal cancer	0.000156	0.00237	CcSEcCtD
Clomifene—Alopecia—Methotrexate—esophageal cancer	0.000156	0.00236	CcSEcCtD
Clomifene—Erythema—Methotrexate—esophageal cancer	0.000153	0.00233	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000153	0.00232	CcSEcCtD
Clomifene—Insomnia—Capecitabine—esophageal cancer	0.000152	0.00231	CcSEcCtD
Clomifene—Paraesthesia—Capecitabine—esophageal cancer	0.000151	0.00229	CcSEcCtD
Clomifene—Dyspnoea—Capecitabine—esophageal cancer	0.00015	0.00227	CcSEcCtD
Clomifene—Back pain—Methotrexate—esophageal cancer	0.000148	0.00225	CcSEcCtD
Clomifene—Vomiting—Cisplatin—esophageal cancer	0.000145	0.0022	CcSEcCtD
Clomifene—Fatigue—Capecitabine—esophageal cancer	0.000145	0.0022	CcSEcCtD
Clomifene—Vision blurred—Methotrexate—esophageal cancer	0.000144	0.00219	CcSEcCtD
Clomifene—Rash—Cisplatin—esophageal cancer	0.000144	0.00218	CcSEcCtD
Clomifene—Pain—Capecitabine—esophageal cancer	0.000144	0.00218	CcSEcCtD
Clomifene—Constipation—Capecitabine—esophageal cancer	0.000144	0.00218	CcSEcCtD
Clomifene—Dermatitis—Cisplatin—esophageal cancer	0.000144	0.00218	CcSEcCtD
Clomifene—Vertigo—Methotrexate—esophageal cancer	0.000138	0.00209	CcSEcCtD
Clomifene—Nausea—Cisplatin—esophageal cancer	0.000135	0.00205	CcSEcCtD
Clomifene—Urticaria—Capecitabine—esophageal cancer	0.000134	0.00203	CcSEcCtD
Clomifene—Tamoxifen—ABCB1—esophageal cancer	0.000133	0.0586	CrCbGaD
Clomifene—Body temperature increased—Capecitabine—esophageal cancer	0.000133	0.00202	CcSEcCtD
Clomifene—Convulsion—Methotrexate—esophageal cancer	0.000133	0.00202	CcSEcCtD
Clomifene—Myalgia—Methotrexate—esophageal cancer	0.000131	0.00198	CcSEcCtD
Clomifene—Chest pain—Methotrexate—esophageal cancer	0.000131	0.00198	CcSEcCtD
Clomifene—Arthralgia—Methotrexate—esophageal cancer	0.000131	0.00198	CcSEcCtD
Clomifene—Hypersensitivity—Capecitabine—esophageal cancer	0.000124	0.00188	CcSEcCtD
Clomifene—Asthenia—Capecitabine—esophageal cancer	0.000121	0.00183	CcSEcCtD
Clomifene—Pruritus—Capecitabine—esophageal cancer	0.000119	0.0018	CcSEcCtD
Clomifene—Diarrhoea—Capecitabine—esophageal cancer	0.000115	0.00174	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000114	0.00173	CcSEcCtD
Clomifene—Insomnia—Methotrexate—esophageal cancer	0.000113	0.00172	CcSEcCtD
Clomifene—Paraesthesia—Methotrexate—esophageal cancer	0.000112	0.0017	CcSEcCtD
Clomifene—Dyspnoea—Methotrexate—esophageal cancer	0.000112	0.00169	CcSEcCtD
Clomifene—Dizziness—Capecitabine—esophageal cancer	0.000111	0.00169	CcSEcCtD
Clomifene—Fatigue—Methotrexate—esophageal cancer	0.000108	0.00164	CcSEcCtD
Clomifene—Pain—Methotrexate—esophageal cancer	0.000107	0.00162	CcSEcCtD
Clomifene—Vomiting—Capecitabine—esophageal cancer	0.000107	0.00162	CcSEcCtD
Clomifene—Rash—Capecitabine—esophageal cancer	0.000106	0.00161	CcSEcCtD
Clomifene—Dermatitis—Capecitabine—esophageal cancer	0.000106	0.00161	CcSEcCtD
Clomifene—Headache—Capecitabine—esophageal cancer	0.000105	0.0016	CcSEcCtD
Clomifene—Nausea—Capecitabine—esophageal cancer	9.98e-05	0.00151	CcSEcCtD
Clomifene—Urticaria—Methotrexate—esophageal cancer	9.94e-05	0.00151	CcSEcCtD
Clomifene—Body temperature increased—Methotrexate—esophageal cancer	9.89e-05	0.0015	CcSEcCtD
Clomifene—Hypersensitivity—Methotrexate—esophageal cancer	9.22e-05	0.0014	CcSEcCtD
Clomifene—Asthenia—Methotrexate—esophageal cancer	8.98e-05	0.00136	CcSEcCtD
Clomifene—Pruritus—Methotrexate—esophageal cancer	8.85e-05	0.00134	CcSEcCtD
Clomifene—Diarrhoea—Methotrexate—esophageal cancer	8.56e-05	0.0013	CcSEcCtD
Clomifene—Dizziness—Methotrexate—esophageal cancer	8.27e-05	0.00126	CcSEcCtD
Clomifene—Vomiting—Methotrexate—esophageal cancer	7.96e-05	0.00121	CcSEcCtD
Clomifene—Rash—Methotrexate—esophageal cancer	7.89e-05	0.0012	CcSEcCtD
Clomifene—Dermatitis—Methotrexate—esophageal cancer	7.88e-05	0.0012	CcSEcCtD
Clomifene—Headache—Methotrexate—esophageal cancer	7.84e-05	0.00119	CcSEcCtD
Clomifene—Nausea—Methotrexate—esophageal cancer	7.43e-05	0.00113	CcSEcCtD
Clomifene—ESR1—Signaling Pathways—ELMO1—esophageal cancer	2.39e-05	0.000176	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.38e-05	0.000176	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ALDOB—esophageal cancer	2.38e-05	0.000175	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AKAP13—esophageal cancer	2.33e-05	0.000172	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	2.33e-05	0.000172	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CA1—esophageal cancer	2.29e-05	0.000169	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—SLC10A2—esophageal cancer	2.29e-05	0.000169	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GAPDH—esophageal cancer	2.29e-05	0.000169	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CRABP1—esophageal cancer	2.27e-05	0.000167	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ADH1B—esophageal cancer	2.27e-05	0.000167	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ENO1—esophageal cancer	2.26e-05	0.000167	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PTGS1—esophageal cancer	2.26e-05	0.000167	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	2.26e-05	0.000167	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PSME1—esophageal cancer	2.23e-05	0.000165	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PSME2—esophageal cancer	2.23e-05	0.000165	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	2.21e-05	0.000163	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—NOTCH2—esophageal cancer	2.17e-05	0.00016	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—TYMP—esophageal cancer	2.17e-05	0.00016	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GNG7—esophageal cancer	2.16e-05	0.000159	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HIST1H2BM—esophageal cancer	2.15e-05	0.000159	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—SLC52A3—esophageal cancer	2.15e-05	0.000159	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—BLVRB—esophageal cancer	2.15e-05	0.000159	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ADH1B—esophageal cancer	2.14e-05	0.000158	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PDE4D—esophageal cancer	2.13e-05	0.000157	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP26A1—esophageal cancer	2.11e-05	0.000156	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CA2—esophageal cancer	2.09e-05	0.000155	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ALOX15—esophageal cancer	2.05e-05	0.000152	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—TYMP—esophageal cancer	2.04e-05	0.000151	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—GNG7—esophageal cancer	2.03e-05	0.00015	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ALDH2—esophageal cancer	2.02e-05	0.000149	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2e-05	0.000147	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP26A1—esophageal cancer	1.99e-05	0.000147	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GSTO1—esophageal cancer	1.96e-05	0.000145	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—TPI1—esophageal cancer	1.96e-05	0.000145	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.95e-05	0.000144	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PLCE1—esophageal cancer	1.95e-05	0.000144	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ADH7—esophageal cancer	1.95e-05	0.000144	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ALOX15—esophageal cancer	1.94e-05	0.000143	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.93e-05	0.000143	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CYP1B1—esophageal cancer	1.92e-05	0.000142	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GSTT1—esophageal cancer	1.92e-05	0.000142	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.92e-05	0.000142	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—XIAP—esophageal cancer	1.9e-05	0.00014	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ALDOB—esophageal cancer	1.88e-05	0.000139	CbGpPWpGaD
Clomifene—EBP—Metabolism—PIK3CA—esophageal cancer	1.86e-05	0.000137	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—TPI1—esophageal cancer	1.85e-05	0.000136	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GSTO1—esophageal cancer	1.85e-05	0.000136	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.84e-05	0.000136	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CA1—esophageal cancer	1.83e-05	0.000135	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—SLC10A2—esophageal cancer	1.83e-05	0.000135	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—SMAD4—esophageal cancer	1.82e-05	0.000135	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.81e-05	0.000134	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GAPDH—esophageal cancer	1.81e-05	0.000133	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ENO1—esophageal cancer	1.8e-05	0.000133	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PTGS1—esophageal cancer	1.8e-05	0.000133	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CTNNA1—esophageal cancer	1.8e-05	0.000133	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CRABP1—esophageal cancer	1.79e-05	0.000132	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CXCL2—esophageal cancer	1.79e-05	0.000132	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PSME2—esophageal cancer	1.78e-05	0.000131	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PSME1—esophageal cancer	1.78e-05	0.000131	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ALDOB—esophageal cancer	1.77e-05	0.000131	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ADH1B—esophageal cancer	1.71e-05	0.000126	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GAPDH—esophageal cancer	1.71e-05	0.000126	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GNG7—esophageal cancer	1.7e-05	0.000126	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CRABP1—esophageal cancer	1.69e-05	0.000125	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CA2—esophageal cancer	1.67e-05	0.000123	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.67e-05	0.000123	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PSME2—esophageal cancer	1.67e-05	0.000123	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PSME1—esophageal cancer	1.67e-05	0.000123	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ANXA1—esophageal cancer	1.66e-05	0.000123	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.66e-05	0.000122	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.66e-05	0.000122	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—HMOX1—esophageal cancer	1.65e-05	0.000122	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.63e-05	0.000121	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—TYMP—esophageal cancer	1.63e-05	0.00012	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.62e-05	0.00012	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SST—esophageal cancer	1.62e-05	0.000119	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GNG7—esophageal cancer	1.61e-05	0.000119	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.6e-05	0.000118	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CREBBP—esophageal cancer	1.6e-05	0.000118	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ALDH2—esophageal cancer	1.6e-05	0.000118	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.59e-05	0.000117	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ABCB1—esophageal cancer	1.59e-05	0.000117	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—GHRL—esophageal cancer	1.58e-05	0.000116	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NOTCH3—esophageal cancer	1.58e-05	0.000116	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.57e-05	0.000116	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.55e-05	0.000115	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ADH7—esophageal cancer	1.55e-05	0.000115	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—FBXW7—esophageal cancer	1.55e-05	0.000114	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ALOX15—esophageal cancer	1.55e-05	0.000114	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.54e-05	0.000113	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYP1B1—esophageal cancer	1.53e-05	0.000113	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GSTT1—esophageal cancer	1.52e-05	0.000112	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ALDH2—esophageal cancer	1.51e-05	0.000111	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—MYC—esophageal cancer	1.5e-05	0.000111	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP2A6—esophageal cancer	1.5e-05	0.000111	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—TPI1—esophageal cancer	1.48e-05	0.000109	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GSTO1—esophageal cancer	1.48e-05	0.000109	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYP19A1—esophageal cancer	1.44e-05	0.000106	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GSTT1—esophageal cancer	1.43e-05	0.000106	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—NOS3—esophageal cancer	1.43e-05	0.000106	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ENO1—esophageal cancer	1.42e-05	0.000105	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PTGS1—esophageal cancer	1.42e-05	0.000105	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP2A6—esophageal cancer	1.42e-05	0.000105	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ALDOB—esophageal cancer	1.41e-05	0.000104	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NOTCH2—esophageal cancer	1.41e-05	0.000104	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CA1—esophageal cancer	1.41e-05	0.000104	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.41e-05	0.000104	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.41e-05	0.000104	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PSME2—esophageal cancer	1.4e-05	0.000104	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PSME1—esophageal cancer	1.4e-05	0.000104	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.36e-05	0.000101	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GAPDH—esophageal cancer	1.36e-05	0.000101	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.36e-05	0.0001	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CRABP1—esophageal cancer	1.35e-05	9.96e-05	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—NOTCH1—esophageal cancer	1.35e-05	9.93e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ENO1—esophageal cancer	1.34e-05	9.91e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PTGS1—esophageal cancer	1.34e-05	9.91e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PSME2—esophageal cancer	1.32e-05	9.76e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PSME1—esophageal cancer	1.32e-05	9.76e-05	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.32e-05	9.71e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—HMOX1—esophageal cancer	1.31e-05	9.7e-05	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PTGS2—esophageal cancer	1.31e-05	9.67e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—TYMP—esophageal cancer	1.3e-05	9.62e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CA2—esophageal cancer	1.29e-05	9.53e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GNG7—esophageal cancer	1.28e-05	9.48e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.27e-05	9.35e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ABCB1—esophageal cancer	1.26e-05	9.31e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TGFBR2—esophageal cancer	1.25e-05	9.25e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.23e-05	9.12e-05	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—CREBBP—esophageal cancer	1.22e-05	9e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP1B1—esophageal cancer	1.21e-05	8.94e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ALDH2—esophageal cancer	1.2e-05	8.88e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ADH7—esophageal cancer	1.2e-05	8.86e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.2e-05	8.86e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.2e-05	8.85e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SMAD4—esophageal cancer	1.19e-05	8.76e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—TPI1—esophageal cancer	1.18e-05	8.7e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.18e-05	8.7e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.16e-05	8.53e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GSTT1—esophageal cancer	1.14e-05	8.45e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP1B1—esophageal cancer	1.14e-05	8.43e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.14e-05	8.4e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.13e-05	8.35e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.13e-05	8.34e-05	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—EP300—esophageal cancer	1.09e-05	8.04e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.09e-05	8.02e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.08e-05	7.95e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP19A1—esophageal cancer	1.07e-05	7.92e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ENO1—esophageal cancer	1.07e-05	7.91e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PTGS1—esophageal cancer	1.07e-05	7.91e-05	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.07e-05	7.91e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CREBBP—esophageal cancer	1.06e-05	7.82e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PSME2—esophageal cancer	1.06e-05	7.8e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PSME1—esophageal cancer	1.06e-05	7.8e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.05e-05	7.76e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.04e-05	7.67e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GNG7—esophageal cancer	1.02e-05	7.56e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—TYMP—esophageal cancer	1.01e-05	7.42e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ABCB1—esophageal cancer	9.97e-06	7.36e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—HMOX1—esophageal cancer	9.79e-06	7.23e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP26A1—esophageal cancer	9.78e-06	7.22e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HIF1A—esophageal cancer	9.71e-06	7.17e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.61e-06	7.09e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ALDH2—esophageal cancer	9.6e-06	7.09e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.53e-06	7.03e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—NOS3—esophageal cancer	9.48e-06	7e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ABCB1—esophageal cancer	9.4e-06	6.94e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KDR—esophageal cancer	9.28e-06	6.85e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GSTT1—esophageal cancer	9.13e-06	6.74e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP1B1—esophageal cancer	9.12e-06	6.73e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GSTO1—esophageal cancer	9.09e-06	6.71e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—TPI1—esophageal cancer	9.09e-06	6.71e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP2A6—esophageal cancer	9.03e-06	6.66e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.99e-06	6.64e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NOTCH1—esophageal cancer	8.75e-06	6.46e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.72e-06	6.43e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PTGS2—esophageal cancer	8.67e-06	6.4e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP19A1—esophageal cancer	8.57e-06	6.33e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PTGS1—esophageal cancer	8.56e-06	6.32e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ENO1—esophageal cancer	8.56e-06	6.32e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PSME2—esophageal cancer	8.43e-06	6.23e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PSME1—esophageal cancer	8.43e-06	6.23e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CREBBP—esophageal cancer	8.43e-06	6.22e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.39e-06	6.19e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CRABP1—esophageal cancer	8.32e-06	6.14e-05	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CA—esophageal cancer	8.06e-06	5.95e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CREBBP—esophageal cancer	7.93e-06	5.85e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GNG7—esophageal cancer	7.91e-06	5.84e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—HMOX1—esophageal cancer	7.82e-06	5.77e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—NOS3—esophageal cancer	7.55e-06	5.57e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.41e-06	5.47e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.37e-06	5.44e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP1B1—esophageal cancer	7.28e-06	5.37e-05	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—MYC—esophageal cancer	7.24e-06	5.34e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—EP300—esophageal cancer	7.21e-06	5.33e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.11e-06	5.25e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NOS3—esophageal cancer	7.1e-06	5.24e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.05e-06	5.2e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP2A6—esophageal cancer	6.97e-06	5.14e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PTGS2—esophageal cancer	6.9e-06	5.1e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP19A1—esophageal cancer	6.84e-06	5.05e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CREBBP—esophageal cancer	6.66e-06	4.92e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ERBB2—esophageal cancer	6.64e-06	4.9e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.61e-06	4.88e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ENO1—esophageal cancer	6.61e-06	4.88e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PSME2—esophageal cancer	6.51e-06	4.8e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PSME1—esophageal cancer	6.51e-06	4.8e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CREBBP—esophageal cancer	6.28e-06	4.64e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—HMOX1—esophageal cancer	6.24e-06	4.61e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.13e-06	4.52e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ABCB1—esophageal cancer	5.99e-06	4.42e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—NOS3—esophageal cancer	5.97e-06	4.4e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CCND1—esophageal cancer	5.87e-06	4.33e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—EP300—esophageal cancer	5.74e-06	4.24e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CDKN1A—esophageal cancer	5.68e-06	4.19e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—NOS3—esophageal cancer	5.62e-06	4.15e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.62e-06	4.15e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PTGS2—esophageal cancer	5.46e-06	4.03e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EP300—esophageal cancer	5.4e-06	3.99e-05	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CA—esophageal cancer	5.34e-06	3.94e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.28e-06	3.9e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PTGS2—esophageal cancer	5.14e-06	3.8e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CREBBP—esophageal cancer	5.02e-06	3.7e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.82e-06	3.56e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MYC—esophageal cancer	4.71e-06	3.47e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.63e-06	3.41e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EGFR—esophageal cancer	4.6e-06	3.4e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—EP300—esophageal cancer	4.54e-06	3.35e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.53e-06	3.34e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—NOS3—esophageal cancer	4.49e-06	3.32e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—EP300—esophageal cancer	4.28e-06	3.16e-05	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CA—esophageal cancer	4.25e-06	3.14e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PTGS2—esophageal cancer	4.11e-06	3.03e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CREBBP—esophageal cancer	4.01e-06	2.96e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CA—esophageal cancer	4e-06	2.95e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—esophageal cancer	3.86e-06	2.85e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—NOS3—esophageal cancer	3.59e-06	2.65e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—EP300—esophageal cancer	3.42e-06	2.52e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CA—esophageal cancer	3.36e-06	2.48e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.28e-06	2.42e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CA—esophageal cancer	3.16e-06	2.34e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.09e-06	2.28e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—NOS3—esophageal cancer	2.77e-06	2.04e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—EP300—esophageal cancer	2.73e-06	2.01e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.53e-06	1.87e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.53e-06	1.87e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—EP300—esophageal cancer	2.11e-06	1.55e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.02e-06	1.49e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.56e-06	1.15e-05	CbGpPWpGaD
